Literature DB >> 8326107

[Long-term prognosis of cystoid macular edema after microsurgery of rhegmatogenous retinal detachment].

M Bonnet1, X Payan.   

Abstract

We reviewed 25 eyes of 24 patients who had undergone successful repair of rhegmatogenous retinal detachment and who showed cystoid macular edema disclosed by routine fluorescein angiography performed 10-12 weeks postoperatively. The follow-up ranged from 18 months to 10 years (average: 60 months). Angiographic CME spontaneously disappeared in 19 eyes (76%). Complete disappearance of CME occurred less than 2 years postoperatively in all eyes. No late recurrence was observed. The final visual acuity was 20/40 or better in 15 eyes (78.9%). The final near reading visual acuity was normal in 16 eyes (84.2%). Angiographic CME was still present in 6 eyes (24%) 2 years postoperatively. It remained unchanged during the follow-up period (average 64 months) in all eyes. Cystoid macular degeneration developed in only 1 of the 6 eyes with chronic angiographic CME. Five of the 6 eyes with chronic CME retained useful near reading visual acuity during the follow-up period. The long-term prognosis of angiographic CME after microsurgical repair of rhegmatogenous retinal detachment appears to be good in most cases.

Entities:  

Mesh:

Year:  1993        PMID: 8326107

Source DB:  PubMed          Journal:  J Fr Ophtalmol        ISSN: 0181-5512            Impact factor:   0.818


  3 in total

1.  Protocol: Effect of intravitreal bevacizumab (avastin) in the treatment of macular edema: A systematic review of randomized controlled trials.

Authors:  Hammad A Qazi
Journal:  J Res Med Sci       Date:  2012-12       Impact factor: 1.852

2.  Intravitreal Fluocinolone Acetonide (ILUVIEN) Implant for the Treatment of Refractory Cystoid Macular Oedema After Retinal Detachment Repair.

Authors:  Fadi Alfaqawi; Ambreen Sarmad; Kholoud Ayesh; Arijit Mitra; Ash Sharma
Journal:  Turk J Ophthalmol       Date:  2018-06-28

3.  Macular edema after rhegmatogenous retinal detachment repair: risk factors, OCT analysis, and treatment responses.

Authors:  Cameron Pole; Ismael Chehaibou; Andrea Govetto; Sean Garrity; Steven D Schwartz; Jean-Pierre Hubschman
Journal:  Int J Retina Vitreous       Date:  2021-01-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.